Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
- PMID: 38223899
- PMCID: PMC10787304
- DOI: 10.1515/med-2023-0865
Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
Abstract
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. There is a need for biomarkers that can be used for the diagnosis of sepsis and the early identification of patients at high risk of death. In this study, we aimed to investigate the relationship between Mid-regional pro-adrenomedullin (MR-proADM), procalcitonin (PCT), and copeptin in sepsis. A total of 28 sepsis, 32 septic shock, and 30 control patients were included in our prospective study. Patients' MR-proADM, PCT, and copeptin levels were recorded. Sequential organ failure assessment scores, length of hospital stay, and 30-day mortality were also recorded. These values were compared between the sepsis, septic shock, and control groups. The mean age of all participants was 64.04 ± 15.83 years. In the study, 37 (61.6%) patients were female and 23 (39.3%) were male. There was no statistically significant difference in gender/age between all patient groups and the control group (for all, p > 0.05). We found a significant difference between the survivors and nonsurvivors in terms of MR-proADM, PCT, and copeptin levels. There was a significant difference between the sepsis and septic shock groups in terms of MR-proADM and PCT. A significant correlation was found between the length of hospital stay and MR-proADM and copeptin. MR-proADM, PCT, and copeptin may be useful in the prognosis of sepsis and to predict the length of stay in hospital and mortality.
Keywords: MR-proADM; copeptin; procalcitonin; sepsis.
© 2023 the author(s), published by De Gruyter.
Conflict of interest statement
Conflict of interest: Authors state no conflict of interest.
Similar articles
-
Diagnostic and prognostic value of procalcitonin and mid-regional pro-adrenomedullin in septic paediatric patients.Eur J Pediatr. 2020 Jul;179(7):1089-1096. doi: 10.1007/s00431-020-03587-7. Epub 2020 Jan 23. Eur J Pediatr. 2020. PMID: 31974673
-
Procalcitonin and MR-Proadrenomedullin Combination with SOFA and qSOFA Scores for Sepsis Diagnosis and Prognosis: A Diagnostic Algorithm.Shock. 2018 Jul;50(1):44-52. doi: 10.1097/SHK.0000000000001023. Shock. 2018. PMID: 29023361
-
Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients.Eur J Clin Invest. 2022 May;52(5):e13753. doi: 10.1111/eci.13753. Epub 2022 Feb 7. Eur J Clin Invest. 2022. PMID: 35128648 Free PMC article.
-
New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure.Ann Transl Med. 2016 Sep;4(17):329. doi: 10.21037/atm.2016.08.65. Ann Transl Med. 2016. PMID: 27713887 Free PMC article. Review.
-
Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review.Healthcare (Basel). 2018 Sep 3;6(3):110. doi: 10.3390/healthcare6030110. Healthcare (Basel). 2018. PMID: 30177659 Free PMC article. Review.
Cited by
-
The Role of Adrenomedullin as a Predictive Marker of the Risk of Death and Adverse Clinical Events: A Review of the Literature.J Clin Med. 2024 Aug 16;13(16):4847. doi: 10.3390/jcm13164847. J Clin Med. 2024. PMID: 39200990 Free PMC article. Review.
-
Sepsis Biomarkers: Advancements and Clinical Applications-A Narrative Review.Int J Mol Sci. 2024 Aug 19;25(16):9010. doi: 10.3390/ijms25169010. Int J Mol Sci. 2024. PMID: 39201697 Free PMC article. Review.
-
Decoding Inflammation: Predicting Sepsis in the ICU.Cureus. 2024 Dec 7;16(12):e75256. doi: 10.7759/cureus.75256. eCollection 2024 Dec. Cureus. 2024. PMID: 39776743 Free PMC article.
References
-
- Font MD, Thyagarajan B, Khanna AK. Sepsis and Septic Shock - Basics of diagnosis, pathophysiology, and clinical decision making. Med Clin North Am. 2020;104(4):573–85. - PubMed
-
- Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;45(3):486–552. - PubMed
-
- Elay G, Al B. Thirty-Day mortality in septic shock patients is directly associated with high disease severity score but not with the length of stay in the emergency department. Eurasian. J Emerg Med. 2020;19(3):172–7.
LinkOut - more resources
Full Text Sources